Cardiotoxicity in a dish: new insights for personalized therapy

feature-image

Play all audios:

Loading...

A recent study identifies differences in human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes from patients with breast cancer who were treated with doxorubicin and either did


or did not develop cardiotoxicity. The results open up new avenues for the development of personalized therapy and the prevention of cardiotoxicity. Access through your institution Buy or


subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online


access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which


are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Ewer, M.S. & Ewer,


S.M. _Nat. Rev. Cardiol._ 12, 547–558 (2015). Article  CAS  Google Scholar  * Burridge, P.W. et al. _Nat. Med._ 22, 547–556 (2016). Article  CAS  Google Scholar  * Burridge, P.W. et al.


_Nat. Methods_ 11, 855–860 (2014). Article  CAS  Google Scholar  * Slamon, D.J. et al. _N. Engl. J. Med._ 344, 783–792 (2001). Article  CAS  Google Scholar  Download references AUTHOR


INFORMATION AUTHORS AND AFFILIATIONS * Mitch Biermann and Timothy J. Kamp are in the Departments of Medicine and Cell and Regenerative Biology, School of Medicine and Public Health,


University of Wisconsin–Madison, Madison, Wisconsin, USA, and the Stem Cell and Regenerative Medicine Center, University of Wisconsin–Madison, Madison, Wisconsin, USA., Mitch Biermann & 


Timothy J Kamp Authors * Mitch Biermann View author publications You can also search for this author inPubMed Google Scholar * Timothy J Kamp View author publications You can also search for


this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Timothy J Kamp. ETHICS DECLARATIONS COMPETING INTERESTS T.J.K. is a consultant for Cellular Dynamics


International. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Biermann, M., Kamp, T. Cardiotoxicity in a dish: new insights for personalized therapy.


_Nat Med_ 22, 459–460 (2016). https://doi.org/10.1038/nm.4095 Download citation * Published: 05 May 2016 * Issue Date: May 2016 * DOI: https://doi.org/10.1038/nm.4095 SHARE THIS ARTICLE


Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided


by the Springer Nature SharedIt content-sharing initiative